Highly selective electrocoagulation therapy: an innovative treatment for lymphangioma circumscriptum

Area of Science:

• Dermatology
• Vascular Malformations
• Minimally Invasive Procedures

Background:

• Lymphangioma circumscriptum (LC) is a microcystic lymphatic malformation affecting skin and mucosa, presenting as vesicles.
• LC causes cosmetic issues, rupture, infection, lymphorrhea, and bleeding.
• Previous treatments like surgery, lasers, and sclerotherapy have shown variable success.

Purpose of the Study:

• To report a novel treatment for lymphangioma circumscriptum (LC).
• To evaluate the safety and efficacy of highly selective electrocoagulation therapy for LC management.

Main Methods:

• A study involving 12 patients (ages 4-31) with LC.
• Treatment administered via electrocoagulation using a specialized isolated needle.
• Data collected on demographics, lesion characteristics, imaging, treatment, and clinical response.

Main Results:

• Near-complete clearance of LC was achieved in all 12 patients.
• Minimal intra- and postoperative complications were noted, including mild pain, scarring, and ulceration.
• No systemic side effects were observed during the mean 8.25-month follow-up.

Conclusions:

• Highly selective electrocoagulation therapy is a promising, minimally invasive treatment for LC.
• The technique appears safe and effective, with acceptable local complications.
• Further studies with larger populations are warranted to confirm these findings.